GRIFOLS SA INH. A EO-,25/ ES0171996087 /
5/3/2024 8:00:12 AM | Chg. +0.024 | Volume | Bid10:00:01 PM | Ask10:00:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
8.552EUR | +0.28% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 7.27 bill.EUR | - | 98.78 |
GlobeNewswire
4/18
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...
GlobeNewswire
4/4
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Scree...
GlobeNewswire
11/15/2023
Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous ...